Combined Data Show Superiority of LAMA/LABA in COPD

medscape.com November 20, 2016

Patients with chronic obstructive pulmonary disease (COPD) experienced significantly fewer acute exacerbations when a long-acting muscarinic antagonist (LAMA) was added to a long-acting beta agonist (LABA) than when an inhaled corticosteroid (ICS) was added.

COPD corticosteroid study therapy

Prone Positioning During ECMO for Severe ARDS

Prone Positioning During ECMO for Severe ARDS

Sepsis Mortality Among ICU Patients with Hematological Malignancy

Sepsis Mortality Among ICU Patients with Hematological Malignancy

Impact of a Rounding Checklist Implementation in the Trauma ICU on Clinical Outcomes

Impact of a Rounding Checklist Implementation in the Trauma ICU on Clinical Outcomes

Prior Exposure to ACEi Increased Cardiovascular Response to Angiotensin-II

Prior Exposure to ACEi Increased Cardiovascular Response to Angiotensin-II

One Night in the ER

Priorities in Critical Care Nursing

Perioperative Hemodynamic Monitoring and Goal Directed Therapy: From Theory to Practice

Cardiac Intensive Care

Textbook of Critical Care

Respiratory Monitoring in Mechanical Ventilation: Techniques and Applications

How Doctors Think

Sepsis: Definitions, Pathophysiology and the Challenge of Bedside Management

Handbook of Sepsis

Textbook of Ventilation, Fluids, Electrolytes and Blood Gases

Handbook of Evidence-Based Critical Care

Handbook of Critical and Intensive Care Medicine

Extracorporeal Life Support: The ELSO Red Book, 6th Edition

ICU Protocols: A Step-wise Approach, Vol II

Nursing Care and ECMO